Focusing on the development and industrialization of nucleic acid medicines

Focusing on the development and industrialization of nucleic acid medicines

Focusing on the development and industrialization of nucleic acid medicines

Possesses a proprietary RNA-based Therapeutic Platform (RTP) independently developed for nucleic acid medicines

News

As one of the few domestic R & D enterprises with special emphasis on innovative nucleic acid-based medicines, we have created proprietary RNA-based Therapeutic Platform (RTP) for development of mRNA-based vaccines and therapeutics to address unmet medical needs.

RongCan Biotech Plans to Initiate Series A Financing Round

RongCan Biotech Plans to Initiate Series A Financing Round

RongCan Biotech Plans to Cooperate with Zhangjiang Hi-tech Park to Set Up a Management Headquarter

RongCan Biotech Plans to Cooperate with Zhangjiang Hi-tech Park to Set Up a Management Headquarter

公司建立了具有自主知识产权的核酸药物RTP研发技术平台，研究和开发临床所需的mRNA（信使核酸）药物，是国内稀缺的核酸类一类创新药研发企业。

RongCan’s Pilot Test Base in Minhang Guanghua Industrial Park Was Officially Put into Operation

RongCan’s Pilot Test Base in Minhang Guanghua Industrial Park Was Officially Put into Operation

荣灿生物致力于基因（核酸）药物的开发及产业化，立志成为从核酸序列设计、mRNA核酸原料合成、递送载体合成，到最终成药的核酸全产业链型公司。公司建立了具有自主知识产权的核酸药物RTP研发技术平台，研究和开发临床所需的mRNA（信使核酸）药物，是国内稀缺的核酸类一类创新药研发企业。

RongCan Biotech Won the Second Prize at the Anhui Selective Trial of China Innovation and Entrepreneurship Competition

RongCan Biotech Won the Second Prize at the Anhui Selective Trial of China Innovation and Entrepreneurship Competition

公司建设了RTP研发平台，主要从事SiRNA和mRNA药物的研发。产品管线涵盖了呼吸系统、心血管系统、实体肿瘤方面的药物以及传染病mRNA疫苗。

RongCan Biotech Signed a Strategic Cooperative Agreement on Clinical Research Services with Shanghai Clinical Research Centre (SCRC)

RongCan Biotech Signed a Strategic Cooperative Agreement on Clinical Research Services with Shanghai Clinical Research Centre (SCRC)

根据IATF的转换要求，我司从2017年4月份开始，制定转换导入计划，分规划阶段、标准培训阶段、体系文件编制或修订阶段、体系文件的试运行阶段、内部审核阶段、管理评审阶段、换证审核阶段等7个阶段逐步开展导入工作。

RongCan Biotech Has Cooperated with the School of Pharmacy at Shanghai Jiao Tong University to Establish a Joint Research Centre

RongCan Biotech Has Cooperated with the School of Pharmacy at Shanghai Jiao Tong University to Establish a Joint Research Centre

根据IATF的转换要求，我司从2017年4月份开始，制定转换导入计划，分规划阶段、标准培训阶段、体系文件编制或修订阶段、体系文件的试运行阶段、内部审核阶段、管理评审阶段、换证审核阶段等7个阶段逐步开展导入工作。